本页面由Tiger Trade Technology Pte. Ltd.提供服务

阿诺医药

7.40
+0.04000.54%
盘后7.450.0500+0.68%16:44 EDT
成交量:25.18万
成交额:179.70万
市值:4.32亿
市盈率:-6.05
高:7.73
开:7.29
低:6.73
收:7.36
52周最高:12.09
52周最低:0.8786
股本:5,843.87万
流通股本:4,021.00万
量比:1.50
换手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):-1.2226
每股收益(LYR):-1.6247
净资产收益率:-138.98%
总资产收益率:-29.81%
市净率:54.59
市盈率(LYR):-4.55

数据加载中...

2025/09/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/10

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/14

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/01/27

SEC问询函

Form CORRESP - Correspondence
2025/01/02

SEC问询函

Form CORRESP - Correspondence
2024/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/04

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/27

SEC问询函

Form CORRESP - Correspondence
2023/09/27

SEC问询函

Form CORRESP - Correspondence
2023/09/27

SEC问询函

Form CORRESP - Correspondence
2023/09/27

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/12

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/12

SEC问询函

Form CORRESP - Correspondence